Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Lymphoma 217Precursor Cell Lymphoblastic Leukemia-Lymphoma 192Lymphoma, Large B-Cell, Diffuse 173Burkitt Lymphoma 91Lymphoma, Non-Hodgkin 90Leukemia 80Lymphoma, Follicular 79Lymphoma, Mantle-Cell 53Hodgkin Disease 46Lymphoma, B-Cell 31Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 30Lymphoma, Large-Cell, Anaplastic 29Lymphoma, T-Cell, Peripheral 28Lymphoma, Large-Cell, Immunoblastic 27Recurrence 24Lymphoma, B-Cell, Marginal Zone 22Leukemia, Lymphocytic, Chronic, B-Cell 21Lymphoma, T-Cell 17Leukemia, Biphenotypic, Acute 17Dendritic Cell Sarcoma, Interdigitating 17Immunoblastic Lymphadenopathy 16Neoplasms 14Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 11HIV Infections 10Waldenstrom Macroglobulinemia 7Enteropathy-Associated T-Cell Lymphoma 7Blast Crisis 7Multiple Myeloma 6Lymphoma, T-Cell, Cutaneous 6Lymphoma, AIDS-Related 6

Interventions

Rituximab 4Doxorubicin 3Cyclophosphamide 3Vincristine 2Prednisone 2Etoposide 2pomalidomide 1merphos 1fludarabine 1brincidofovir 1Zidovudine 1Tomography, X-Ray Computed 1Polymerase Chain Reaction 1Nivolumab 1Methotrexate 1Leucovorin 1Interferons 1In Situ Hybridization 1Immunohistochemistry 1Hydroxyurea 1Flow Cytometry 1Echocardiography 1EPOCH protocol 1Cytogenetic Analysis 1Caves 1Brentuximab Vedotin 1Blotting, Western 1AP 1903 reagent 13-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Epstein-Barr Virus Infections × Vincristine × Lymphoid × Clear all
NCT05389423 2026-06-01

Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
25 enrolled
Lymphoid

Plasmablastic Lymphoma, Burkitt Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Epstein-Barr Virus Infections

NCT00001379 2025-06-19

Treatment and Natural History Study of Lymphomatoid Granulomatosis

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
94 enrolled 20 charts
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Lymphomatoid Granulomatosis, Lymphoproliferative Disorders, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡